SEC 13F Intelligence

Slate Path Capital LP / IRWD

Slate Path Capital LP’s Ironwood Pharmaceuticals Inc Position

Does Slate Path Capital LP own Ironwood Pharmaceuticals Inc (IRWD)? Not currently — the last reported position was 2.64M shares worth $27M in Q2 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$27M
Q2 2020
Shares
2.64M
% of Portfolio
+1.61%
Quarters Held
2
position exited

Position History IRWD

Reported value by quarter
Q1 ’20: $14MQ1 ’20Q2 ’20: $27MQ2 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20202.64M$27M+1.61%
Q1 20201.34M$14M+1.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Slate Path Capital LP’s full portfolio or all institutional holders of IRWD.